294 related articles for article (PubMed ID: 6332683)
21. Synthesis, mass spectral characterization and immunoadjuvant activity of some novel lipophilic derivatives of muramyl dipeptides.
Jain RK; Gupta CM; Saxena RK; Saxena RP; Saxena KC; Shukla R; Anand N; Costello CE
Chem Phys Lipids; 1986; 41(3-4):237-64. PubMed ID: 3815623
[TBL] [Abstract][Full Text] [Related]
22. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
Bahr GM; Modabber FZ; Morin A; Terrier M; Eyquem A; Chedid L
Clin Exp Immunol; 1984 Jul; 57(1):178-86. PubMed ID: 6744667
[TBL] [Abstract][Full Text] [Related]
23. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
24. Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity.
Kosugi A; Shima J; Sano H; Ogata M; Kusama T; Fujiwara H; Hamaoka T
Infect Immun; 1986 Dec; 54(3):768-73. PubMed ID: 3491048
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharide.
Kurzman ID; Shi F; MacEwen EG
Vet Immunol Immunopathol; 1993 Sep; 38(1-2):45-56. PubMed ID: 8256437
[TBL] [Abstract][Full Text] [Related]
26. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
[TBL] [Abstract][Full Text] [Related]
27. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
[No Abstract] [Full Text] [Related]
28. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
[TBL] [Abstract][Full Text] [Related]
29. Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines.
Nagao S; Tanaka A; Onozaki K; Hashimoto T
Cell Immunol; 1982 Jul; 71(1):1-11. PubMed ID: 6754096
[No Abstract] [Full Text] [Related]
30. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity.
Hamaoka T; Takai Y; Kosugi A; Mizushima Y; Shima J; Kusama T; Fujiwara H
Cancer Immunol Immunother; 1985; 20(3):183-8. PubMed ID: 2933141
[TBL] [Abstract][Full Text] [Related]
31. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
Todate A; Suda T; Kuwata H; Chida K; Nakamura H
J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
[TBL] [Abstract][Full Text] [Related]
33. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro].
Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE
Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699
[TBL] [Abstract][Full Text] [Related]
34. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
Löwy I; Leclerc C; Bourgeois E; Chedid L
J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
[TBL] [Abstract][Full Text] [Related]
37. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent.
Nagao S; Akagawa KS; Yamada K; Yagawa K; Tokunaga T; Kotani S
Microbiol Immunol; 1990; 34(3):323-35. PubMed ID: 2352499
[TBL] [Abstract][Full Text] [Related]
38. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
39. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of macrophage migration by muramyl peptides.
Nagao S; Tanaka A; Yamamoto Y; Koga T; Onoue K; Shiba T; Kusumoto K; Kotani S
Infect Immun; 1979 May; 24(2):308-12. PubMed ID: 457276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
